Posted by Robert Ring, PhD, Autism Speaks vice president of translational research.
I want to point out a recent review article published in the journal Nature Reviews: Drug Discovery. This article provides an excellent introduction to EU-AIMS, a massive five-year research program focused solely on autism. EU-AIMS, short for European Autism Interventions – A Multicentre Study for Developing New Medications, was launched earlier this year in Europe. The collaboration brings together in a non-competitive way 24 academic research center across Europe, global pharmaceutical companies and patient advocacy organizations in Europe. The collaboration will focus on accelerating the translation of basic science discoveries into medicines for autism. http://www.autismspeaks.org/blog/2012/12/18/world%E2%80%99s-largest-autism-project-gets-good-press?utm_source=social-media&utm_medium=text-link&utm_campaign=espeaks
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment